182 related articles for article (PubMed ID: 28234914)
1. Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model.
Curry A; Khatri I; Kos O; Zhu F; Gorczynski R
PLoS One; 2017; 12(2):e0171586. PubMed ID: 28234914
[TBL] [Abstract][Full Text] [Related]
2. Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy.
Gorczynski RM; Chen Z; Erin N; Khatri I; Podnos A
PLoS One; 2014; 9(11):e113597. PubMed ID: 25409195
[TBL] [Abstract][Full Text] [Related]
3. Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response.
Erin N; Podnos A; Tanriover G; Duymuş Ö; Cote E; Khatri I; Gorczynski RM
Oncogene; 2015 Jul; 34(29):3860-70. PubMed ID: 25263452
[TBL] [Abstract][Full Text] [Related]
4. Role of CD200 expression in regulation of metastasis of EMT6 tumor cells in mice.
Gorczynski RM; Clark DA; Erin N; Khatri I
Breast Cancer Res Treat; 2011 Nov; 130(1):49-60. PubMed ID: 21165772
[TBL] [Abstract][Full Text] [Related]
5. Further evidence for a role of tumor CD200 expression in breast cancer metastasis: decreased metastasis in CD200R1KO mice or using CD200-silenced EMT6.
Podnos A; Clark DA; Erin N; Yu K; Gorczynski RM
Breast Cancer Res Treat; 2012 Nov; 136(1):117-27. PubMed ID: 23053647
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice.
Gorczynski RM; Chen Z; Diao J; Khatri I; Wong K; Yu K; Behnke J
Breast Cancer Res Treat; 2010 Sep; 123(2):405-15. PubMed ID: 19953316
[TBL] [Abstract][Full Text] [Related]
7. CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1.
Erin N; Dilmaç S; Curry A; Duymuş Ö; Tanriover G; Prodeus A; Gariepy J; Gorczynski RM
Cancer Immunol Immunother; 2020 Jan; 69(1):103-114. PubMed ID: 31811336
[TBL] [Abstract][Full Text] [Related]
8. Effect of CD200 and CD200R1 expression within tissue grafts on increased graft survival in allogeneic recipients.
Yu K; Chen Z; Gorczynski R
Immunol Lett; 2013 Jan; 149(1-2):1-8. PubMed ID: 23178470
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an in vitro model system to explore control of tumor invasion of EMT6 and 4THM breast tumors by CD200:CD200R interactions.
Gorczynski RM; Erin N; Maqbool T; Gorczynski CP; Gorczynski LY
Breast Cancer; 2018 Sep; 25(5):547-559. PubMed ID: 29532324
[TBL] [Abstract][Full Text] [Related]
10. Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling.
Gorczynski RM; Chen Z; Khatri I; Podnos A; Yu K
Breast Cancer Res Treat; 2013 Nov; 142(2):271-82. PubMed ID: 24166280
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD200R2, anti-IL-9, anti-IL-35, or anti-TGF-β abolishes increased graft survival and Treg induction induced in cromolyn-treated CD200R1KO.CD200tg mice.
Gorczynski R; Yu K; Chen Z
Transplantation; 2014 Jan; 97(1):39-46. PubMed ID: 24142033
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy of established tumors by antibodies targeting immune activating and suppressing molecules.
Takeda K; Kojima Y; Uno T; Hayakawa Y; Teng MW; Yoshizawa H; Yagita H; Gejyo F; Okumura K; Smyth MJ
J Immunol; 2010 May; 184(10):5493-501. PubMed ID: 20400706
[TBL] [Abstract][Full Text] [Related]
13. A comparison of serum miRNAs influencing metastatic growth of EMT6 vs 4THM tumor cells in wild-type and CD200R1KO mice.
Gorczynski RM; Zhu F; Chen Z; Kos O; Khatri I
Breast Cancer Res Treat; 2017 Apr; 162(2):255-266. PubMed ID: 28160157
[TBL] [Abstract][Full Text] [Related]
14. Treatment of established tumor is associated with ICAM-1 upregulation and reversed by CD8 depletion in a tumor necrosis factor-alpha gene transfected mouse mammary tumor.
Matory YL; Dorfman DM; Wu L; Chen M; Goedegebuure P; Eberlein TJ
Pathobiology; 1999; 67(4):186-95. PubMed ID: 10738180
[TBL] [Abstract][Full Text] [Related]
15. MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors.
Juric V; O'Sullivan C; Stefanutti E; Kovalenko M; Greenstein A; Barry-Hamilton V; Mikaelian I; Degenhardt J; Yue P; Smith V; Mikels-Vigdal A
PLoS One; 2018; 13(11):e0207255. PubMed ID: 30500835
[TBL] [Abstract][Full Text] [Related]
16. CD200 is overexpressed in neuroblastoma and regulates tumor immune microenvironment.
Xin C; Zhu J; Gu S; Yin M; Ma J; Pan C; Tang J; Zhang P; Liu Y; Bai XF; Mo X; Xu M; Zhu H
Cancer Immunol Immunother; 2020 Nov; 69(11):2333-2343. PubMed ID: 32514618
[TBL] [Abstract][Full Text] [Related]
17. ICAM-1-LFA-1 Dependent CD8+ T-Lymphocyte Aggregation in Tumor Tissue Prevents Recirculation to Draining Lymph Nodes.
Yanguas A; Garasa S; Teijeira Á; Aubá C; Melero I; Rouzaut A
Front Immunol; 2018; 9():2084. PubMed ID: 30258446
[TBL] [Abstract][Full Text] [Related]
18. Serum-derived exosomes from mice with highly metastatic breast cancer transfer increased metastatic capacity to a poorly metastatic tumor.
Gorczynski RM; Erin N; Zhu F
Cancer Med; 2016 Feb; 5(2):325-36. PubMed ID: 26725371
[TBL] [Abstract][Full Text] [Related]
19. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
20. Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice.
Mastini C; Becker PD; Iezzi M; Curcio C; Musiani P; Forni G; Cavallo F; Guzmán CA
Curr Cancer Drug Targets; 2008 May; 8(3):230-42. PubMed ID: 18473736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
